superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2021-12-31
- Valid until
- 2022-03-31
- Published
- 2022-02-18
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 35,399,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Abbott Laboratories total equity: 35,802,000,000 United States dollar", as of 2021-12-31 (until 2022-03-31). Claim clm_962B09128298, https://asof.is/claim/clm_962B09128298, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000110465922025141/0001104659-22-025141-index.htm.
APA
AsOf. (2021). Abbott Laboratories total equity: 35,802,000,000 United States dollar (as of 2021-12-31 (until 2022-03-31)) [Record clm_962B09128298]. Retrieved November 9, 2026, from https://asof.is/claim/clm_962B09128298 (source: https://www.sec.gov/Archives/edgar/data/1800/000110465922025141/0001104659-22-025141-index.htm)
BibTeX
@misc{asof_clm_962B09128298,
author = {AsOf},
title = {Abbott Laboratories total equity: 35,802,000,000 United States dollar},
year = {2021},
howpublished = {\url{https://asof.is/claim/clm_962B09128298}},
note = {Claim clm\_962B09128298, as of 2021-12-31 (until 2022-03-31); source: https://www.sec.gov/Archives/edgar/data/1800/000110465922025141/0001104659-22-025141-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_962B09128298.md/v1/claims/clm_962B09128298submit a correction